Jivi Market Report 2026

Jivi Market Overview

• The Jivi market growth in the historic period has been driven by frequent bleeding episodes in hemophilia a, limitations of standard factor viii therapies • Market expansion is supported by rising use of long acting clotting factors, increasing access to home infusion • Growth Driver: Rising Hemophilia Prevalence Driving Growth In The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Jivi Market?

Jivi is a recombinant factor VIII (antihemophilic factor) medication used to treat and prevent bleeding episodes in individuals with hemophilia A, a genetic blood-clotting disorder. It works by replacing the missing Factor VIII protein, essential for blood clotting, and helps reduce the frequency of bleeding when used as part of a prophylactic regimen. Jivi is notable for its extended half-life, allowing fewer injections compared to traditional Factor VIII therapies, thus improving patient convenience and adherence. The main formulations in the jivi market are lyophilized powder for reconstitution and ready-to-use formulations. Jivi lyophilized powder for reconstitution is a form of Jivi therapy that is freeze-dried into a powder, which is then reconstituted with a solvent before administration. The available routes of administration for Jivi include both intravenous and subcutaneous methods. The product is used for various indications such as treating hemophilia A, providing prophylaxis, and offering on-demand treatment for bleeding episodes. Jivi is distributed through direct sales, wholesalers, distributors, and retail pharmacies. The key end-use settings for Jivi include hospitals, hemophilia treatment centers, specialty clinics, and home healthcare environments.

What Is The Jivi Market Growth Forecast?

The growth in the forecast period can be attributed to rising use of long acting clotting factors, increasing access to home infusion, expansion of pediatric hemophilia care, supportive reimbursement policies, innovation in recombinant therapies. Major trends in the forecast period include growing adoption of extended half life factor viii, shift toward prophylactic hemophilia management, reduced injection frequency preferences, expansion of home based hemophilia care, improved patient adherence to therapy.

Global Jivi Market Segmentation

1) By Formulation: Lyophilized Powder For Reconstitution, Ready-to-use Formulations 2) By Route of Administration: Intravenous, Subcutaneous 3) By Indication: Treatment Of Hemophilia A, Prophylaxis, On-demand Treatment For Bleeding Episodes 4) By Distribution Channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies 5) By End Use: Hospitals, Hemophilia Treatment Centres, Specialty Clinics, Home Healthcare Settings

What Are The Drivers Of The Jivi Market?

The rising prevalence of hemophilia is expected to propel the growth of the jivi market going forward. Hemophilia is attributed to genetic mutations in the X-linked genes responsible for producing clotting factors, leading to insufficient or defective clotting factors VIII (hemophilia A) or IX (hemophilia B), which impair the blood's ability to clot effectively. The prevalence of hemophilia is growing due to improved diagnostic capabilities, better awareness, and increased reporting of cases worldwide. Jivi helps hemophilia patients by replacing the deficient Factor VIII with a long-acting recombinant therapy, aiding blood clotting to prevent or control bleeding episodes, while its extended half-life reduces dosing frequency, enhancing patient convenience and adherence. For instance, in April 2025, according to Hemophilia News Today, a US-based medical news platform, the estimated number of individuals living with hemophilia worldwide reached approximately 836,000, including about 284,000 people with the severe form of the disorder. Thus, the rising prevalence of hemophilia is driving the growth of the jivi industry. The increasing focus on personalized medicine is expected to fuel the growth of the jivi market going forward. Personalized medicine is a healthcare strategy that customizes treatments and therapies according to a person's genetic makeup, environment, and lifestyle. Several factors drive the demand for personalized medicine, such as advancements in genomic medicine, an increase in chronic diseases, improved diagnostic tools, and a patient-centered approach to healthcare. Jivi helps as a personalized medicine by offering individualized treatment for hemophilia A patients, as its extended half-life allows for tailored dosing schedules based on patient needs, enhancing adherence and reducing bleeding episodes. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and healthcare organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, the increasing focus on personalized medicine is driving the growth of the jivi industry. Increasing research and development investments are expected to accelerate the growth of the jivi market. Research and development investments are attributed to the need for innovative therapies that address unmet medical needs, enhance treatment efficacy, and improve patient outcomes in various therapeutic areas. Research and development investments in Jivi enhance its efficacy, safety, and convenience by improving its extended half-life, enabling less frequent dosing, and increasing patient adherence, while also supporting advancements in personalized medicine for tailored treatment plans. For instance, in December 2024, according to Focus2030, a France-based civil society organization, Gavi's 2026-2030 Investment Opportunity details the need for $9 billion, including $1.7 billion for the International Finance Facility for Immunization, to immunize an additional 500 million children by 2030, saving 8 to 9 million lives. Thus, increasing research and development investments are driving the growth of the jivi industry.

Key Players In The Global Jivi Market

Major companies operating in the jivi market are Bayer AG

Regional Insights

North America was the largest region in the jivi market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Jivi Market?

The jivi market consists of sales of prophylactic dosing regimens and injectable formulations. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Jivi Market Report 2026?

The jivi market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the jivi industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.